Tasigna

The Top Line
Podcast

A closer look at pharma’s top patent losses in 2025

This week on "The Top Line," we explore the potential impacts of this year's sizable patent cliff on the pharma industry at large.
clock time delay cancelled month year hour

The top 10 drugs losing US exclusivity in 2025

Mar 17, 2025 3:00am
stop light green

Azurity scores FDA nod for new formulation of Novartis' Tasigna

Nov 15, 2024 10:55am
Novartis

Novartis will let generic Tasigna to be provided to poor nations

Jun 23, 2023 10:01am
hands holding globe

BMS, Novartis, Roche join new coalition for cancer drug access

May 20, 2022 10:50am
Novartis

Novartis wins CML nod for new Gleevec follow-on Scemblix

Nov 1, 2021 6:51am